Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Inhaled Methoxyflurane for Pain Management in Nasal Bone Fracture Reduction : A Randomized, Double-Blind, Placebo-Controlled Trial

NCT04332159 is registered in ClinicalTrials.gov with Université de Sherbrooke as lead sponsor.

NCT NCT04332159
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04332159 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Inhaled Methoxyflurane for Pain Management in Nasal Bone Fracture Reduction : A Randomized, Double-Blind, Placebo-Controlled Trial
Lead sponsor
Université de Sherbrooke
Phase
Phase 3
Overall status
Unknown status
Start date
October 10, 2019
Completion date
March 30, 2021
Enrollment
34 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

nasal fracture, pain, acute